Clinical Trials Browser

Phase 2 × Lung Neoplasms × tipifarnib × Clear all

NCT00005041 2012-11-09

R115777 in Treating Patients With Relapsed Small Cell Lung Cancer

Phase 2 Completed

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00005989 2011-08-04

R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms